Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease

Genetic polymorphisms influence the magnitude of the cytokine response after an inflammatory stimulus. To determine whether such polymorphisms might play a role in Kawasaki disease (KD), we analyzed white and Japanese children with KD and control populations for two polymorphic loci in which the A allele is associated with high tumor necrosis factor-α secretion. The lymphotoxin-α+250 A/A genotype was overrepresented among white children with KD compared with controls (0.59 versus 0.36;p = 0.013). The tumor necrosis factor-α−308 A/G genotype was overrepresented among whites with KD who had coronary artery abnormalities compared with those with normal echocardiograms (0.36 versus 0.09;p = 0.044). No significant difference was seen at either locus between Japanese children with KD and Japanese controls. The increased frequency of the high secretor alleles in white children with KD suggests that these loci may be related to susceptibility to KD and to outcome after disease.

[1]  M. Melish,et al.  Mucocutaneous lymph node syndrome in the United States. , 1976, American journal of diseases of children.

[2]  A. Blakemore,et al.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. , 1992, Human molecular genetics.

[3]  Bernard R. Rosner,et al.  Fundamentals of Biostatistics. , 1992 .

[4]  W. Fiers,et al.  Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome , 1986, The Journal of experimental medicine.

[5]  I. Matsuda,et al.  HLA antigens in mucocutaneous lymph node syndrome. , 1977, American journal of diseases of children.

[6]  H. Rus,et al.  Binding of a protein to an AU-rich domain of tumour necrosis factor alpha mRNA as a 35 kDa complex and its regulation in primary rat astrocytes. , 1996, The Biochemical journal.

[7]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. , 1993, European journal of immunology.

[8]  M. Molyneux,et al.  Tumor necrosis factor and disease severity in children with falciparum malaria. , 1989, The New England journal of medicine.

[9]  A. Kimura,et al.  Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese , 1998 .

[10]  C. Aghajanian,et al.  Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. , 1997, Cancer research.

[11]  K. Yabuta,et al.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.

[12]  M. Newport,et al.  Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. , 1996, The Journal of infectious diseases.

[13]  A. Krensky,et al.  HLA antigens in mucocutaneous lymph node syndrome in New England. , 1981, Pediatrics.

[14]  F. Stüber,et al.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.

[15]  E. Silverman,et al.  Spontaneous tumor necrosis factor production in Kawasaki disease. , 1989, The Journal of pediatrics.

[16]  K. Itoh,et al.  Analysis of tumor necrosis factor‐α production and polymorphisms of the tumor necrosis factor‐α gene in individuals with a history of Kawasaki disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[17]  S. Shulman,et al.  Immunoglobulin allotypic markers in Kawasaki disease. , 1993, The Journal of pediatrics.

[18]  C. Y. Lin,et al.  Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). , 1987, Annals of allergy.

[19]  Y. Nagamachi,et al.  10.5‐kb homozygote of tumor necrosis factor‐beta gene is associated with a better prognosis in gastric cancer patients , 1995, Cancer.

[20]  H. Yanagawa,et al.  Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. , 1995, Archives of pediatrics & adolescent medicine.

[21]  B. Gilchrest,et al.  Post-Transcriptional Regulation of UV Induced TNF-α Expression , 1998 .

[22]  A. Forrest,et al.  Letter: Procaine and malignant hyperthermia. , 1974, Lancet.

[23]  L. Abraham,et al.  The −308 tumor necrosis factor-α promoter polymorphism effects transcription , 1997 .

[24]  S. Koike,et al.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. , 1975, The Journal of pediatrics.

[25]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Krensky,et al.  Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. , 1983, Human immunology.

[27]  T. Kawasaki,et al.  HLA antigens in Kawasaki disease. , 1978, Pediatrics.

[28]  W. Klitz,et al.  The HLA class II region and susceptibility to Kawasaki disease. , 1992, Tissue antigens.

[29]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[30]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[31]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .

[32]  D. Morens,et al.  National surveillance of Kawasaki disease. , 1980, Pediatrics.

[33]  D. Kwiatkowski,et al.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. , 1994, Nature.

[34]  J. Belaiche,et al.  Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans , 1998, Clinical and experimental immunology.

[35]  R. Geha,et al.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. , 1986, The Journal of clinical investigation.

[36]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.

[37]  A. Krensky,et al.  Epedimic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome , 1983 .

[38]  C. Miller‐Graziano,et al.  Increased monocyte TNF‐α message stability contributes to trauma patients' increased TNF production , 1997, Journal of leukocyte biology.

[39]  P. Pelkonen,et al.  Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. , 1989, The Journal of laboratory and clinical medicine.

[40]  L. Fugger,et al.  NcoI Restriction Fragment Length Polymorphism (RFLP) of the Tumour Necrosis Factor (TNFα) Region in Primary Biliary Cirrhosis and in Healthy Danes , 1989, Scandinavian journal of immunology.

[41]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[42]  Y. Danon,et al.  HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients. , 2008, Tissue antigens.

[43]  S. Shulman,et al.  Nationwide survey of Kawasaki disease and acute rheumatic fever. , 1991, The Journal of pediatrics.

[44]  D. Leung,et al.  Immunologic aspects of Kawasaki disease: Implications for pathogenesis and therapy , 1991 .